IMGN Stock News

Popular stocks:

NVIDIA

TOP Stocks:

Shares of other companies:

ImmunoGen (IMGN) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 3, 2023 (08:16)

Sector: Healthcare

The share price of ImmunoGen, Inc. (IMGN) now

What analysts predict: $23

52-week High/Low: $20.69 / $3.605

50/200 Day Moving Average: $15.08 / $12.55

This figure corresponds to the Average Price over the previous 50/200 days. For ImmunoGen stocks, the 50-day moving average is the support level today.

For ImmunoGen stocks, the 200-day moving average is the support level today.

Are you interested in ImmunoGen, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the ImmunoGen stock price in 2023, 2024, 2025, 2026, 2027. How much will one ImmunoGen share be worth in 2023 - 2027?

When should I take profit in ImmunoGen stock? When should I record a loss on ImmunoGen stock? What are analysts' forecasts for ImmunoGen stock? What is the future of ImmunoGen stock? We forecast ImmunoGen stock performance using neural networks based on historical data on ImmunoGen stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

ImmunoGen stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for ImmunoGen shares. This happens once a day.

Historical and forecast chart of ImmunoGen stock

The chart below shows the historical price of ImmunoGen stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ImmunoGen stock price can be found in the table below.

Long-term forecasts by years.

ImmunoGen, Inc., a clinical-stage biotechnology company, is developing antibody-drug conjugate (ADC) therapies for cancer. Its candidate products include mirvetuximab soravtansine, an alpha-folate receptor-targeted ADC that is in phase III clinical trials for the treatment of platinum-resistant ovarian cancer; and IMGN632, an ADC targeting CD123, which is in phase I clinical trials for the treatment of AML and blast plasmacytoid dendritic cell neoplasms.

ImmunoGen daily forecast for a month

Date	Target	Pes.	Opt.	Vol., %
Dec 05	29.88	29.70	30.29	1.99
Dec 06	29.76	29.55	30.30	2.52
Dec 07	29.13	28.63	29.48	2.97
Dec 08	28.97	28.60	29.49	3.12
Dec 09	29.48	29.00	29.61	2.13
Dec 10	30.03	29.50	30.32	2.81
Dec 11	30.16	29.72	30.37	2.17
Dec 12	29.82	29.44	30.22	2.66
Dec 13	29.22	28.91	29.55	2.23
Dec 14	28.85	28.56	29.33	2.69
Dec 15	28.37	28.17	28.61	1.58
Dec 16	28.05	27.53	28.25	2.62
Dec 17	28.45	28.17	28.77	2.14
Dec 18	28.25	27.93	28.71	2.79
Dec 19	28.54	28.33	28.77	1.55
Dec 20	28.60	28.20	28.82	2.22
Dec 21	28.37	27.97	28.84	3.10
Dec 22	28.32	28.00	28.80	2.86
Dec 23	28.50	28.02	28.98	3.39
Dec 24	28.57	28.08	29.06	3.49
Dec 25	28.58	28.17	28.75	2.03
Dec 26	28.79	28.53	29.14	2.14
Dec 27	28.87	28.45	29.27	2.89
Dec 28	28.63	28.11	28.91	2.83
Dec 29	28.72	28.20	29.19	3.54
Dec 30	29.06	28.71	29.20	1.70
Dec 31	28.83	28.40	29.11	2.50
Jan 01	28.37	27.87	28.70	2.95
Jan 02	28.37	28.01	28.83	2.91
Jan 03	28.50	28.30	28.89	2.11

ImmunoGen Daily Price Targets

ImmunoGen Stock Forecast 12-05-2023.

Forecast target price for 12-05-2023: $29.88.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 1.951%.
Pessimistic target level: 29.70
Optimistic target level: 30.29

ImmunoGen Stock Forecast 12-06-2023.

Forecast target price for 12-06-2023: $29.76.
Negative dynamics for ImmunoGen shares will prevail with possible volatility of 2.462%.
Pessimistic target level: 29.55
Optimistic target level: 30.30

ImmunoGen Stock Forecast 12-07-2023.

Forecast target price for 12-07-2023: $29.13.
Negative dynamics for ImmunoGen shares will prevail with possible volatility of 2.887%.
Pessimistic target level: 28.63
Optimistic target level: 29.48

ImmunoGen Stock Forecast 12-08-2023.

Forecast target price for 12-08-2023: $28.97.
Negative dynamics for ImmunoGen shares will prevail with possible volatility of 3.027%.
Pessimistic target level: 28.60
Optimistic target level: 29.49

ImmunoGen Stock Forecast 12-09-2023.

Forecast target price for 12-09-2023: $29.48.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 2.084%.
Pessimistic target level: 29.00
Optimistic target level: 29.61

ImmunoGen Stock Forecast 12-10-2023.

Forecast target price for 12-10-2023: $30.03.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 2.733%.
Pessimistic target level: 29.50
Optimistic target level: 30.32

IMGN (IMGN) Monthly Stock Prediction for 2023

Month	Target	Pes.	Opt.	Vol., %
Dec.	18.05	17.29	19.11	9.49

Full forecast for 2023

ImmunoGen forecast for this year

ImmunoGen Stock Prediction for Dec 2023

An downtrend is forecast for this month with an optimal target price of $18.0507. Pessimistic: $17.29. Optimistic: $19.11

ImmunoGen (IMGN) Monthly Stock Prediction for 2024

Month	Target	Pes.	Opt.	Vol., %
Jan	20.16	19.41	21.25	8.68
Feb	19.35	17.66	20.48	13.75
Mar	19.75	18.57	21.92	15.28
Apr	17.80	17.24	19.72	12.59
May	17.77	16.86	19.80	14.81
Jun	17.66	17.08	18.99	10.05
Jul	18.88	17.92	20.95	14.47
Aug	19.22	17.75	21.18	16.20
Sep	16.80	15.24	17.33	12.07
Oct	17.15	15.79	19.21	17.81
Nov	15.66	15.14	17.54	13.66
Dec	17.89	16.58	19.77	16.15

Full forecast for 2024

ImmunoGen (IMGN) Monthly Stock Prediction for 2025

Month	Target	Pes.	Opt.	Vol., %
Jan	20.44	18.79	21.94	14.39
Feb	19.92	18.25	20.97	12.97
Mar	19.74	18.62	20.60	9.63
Apr	22.26	20.62	23.86	13.57
May	21.92	20.71	23.21	10.77
Jun	24.52	22.39	26.47	15.42
Jul	22.87	20.19	24.75	18.43
Aug	21.74	19.52	22.88	14.68
Sep	21.38	19.61	23.30	15.83
Oct	21.63	20.69	23.65	12.49
Nov	22.41	20.53	24.87	17.44
Dec	25.37	22.82	27.96	18.38

Full forecast for 2025

ImmunoGen (IMGN) Monthly Stock Prediction for 2026

Month	Target	Pes.	Opt.	Vol., %
Jan	26.82	24.85	29.27	15.12
Feb	25.77	23.92	27.36	12.58
Mar	23.03	21.89	24.06	9.04
Apr	22.16	20.83	23.69	12.07
May	20.40	19.42	22.76	14.66
Jun	21.66	19.41	22.73	14.58
Jul	21.53	19.88	23.85	16.65
Aug	22.59	20.46	24.96	18.05
Sep	25.10	22.24	25.93	14.23
Oct	27.43	24.55	28.46	13.73
Nov	28.38	26.00	31.06	16.31
Dec	31.78	30.50	34.98	12.81

Full forecast for 2026

ImmunoGen (IMGN) Monthly Stock Prediction for 2027

Month	Target	Pes.	Opt.	Vol., %
Jan	36.27	32.51	39.86	18.43
Feb	40.73	38.65	43.90	11.97
Mar	37.43	33.33	40.01	16.70
Apr	34.68	30.52	38.79	21.32
May	35.56	34.23	38.60	11.33
Jun	37.80	35.53	42.05	15.51
Jul	35.99	33.13	37.82	12.42
Aug	36.42	32.70	37.68	13.19
Sep	36.15	32.35	39.24	17.55
Oct	33.81	31.38	35.74	12.20
Nov	34.42	33.24	36.08	7.87
Dec	33.75	32.64	35.12	7.06

Full forecast for 2027

ImmunoGen information and performance

ImmunoGen Address

830 WINTER ST, WALTHAM, MA, US

Market Capitalization: 4 276 200 000 $

Market capitalization of the ImmunoGen, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of IMGN shares in the company outstanding by the market price of one share.

EBITDA: -78 459 000 $

EBITDA of ImmunoGen is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0113

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.28

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 4.078

Quarterly Revenue Growth YOY: 6.38

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 8.87

Enterprise Value (EV) /Revenue

EV To EBITDA: -4.372

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 266264000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Related stocks from Healthcare sector

CVS Health Corp. (CVS)

Zomedica Corp. (ZOM)

AN2 Therapeutics, Inc. (ANTX)

Sundial Growers Inc. (SNDL)

Zoetis Inc. (ZTS)

Viatris Inc. (VTRS)

SCYNEXIS, Inc. (SCYX)

IMV Inc. (IMV)

Kura Oncology, Inc. (KURA)

UnitedHealth Group, Inc. (UNH)

Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.

<img data-src="/images/stock/IMGN.svg" class="img_30 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="img_30" src="/images/stock/IMGN.svg"> ImmunoGen (IMGN) Stock Forecast for 2023 – 2026. Sell or Buy?